Buhari tells Gavi Alliance Nigeria is Making Progress Towards Achieving Targets On Immunisation, PHC’

26 Feb Buhari tells Gavi Alliance Nigeria is Making Progress Towards Achieving Targets On Immunisation, PHC’

President Muhammadu Buhari on Friday in Abuja, said steady progress was being made in achieving the targets set out in Nigeria’s Strategy for Immunisation and Primary Health Care (PHC) System.

Buhari spoke on Friday when he received The Gavi Alliance High Level Mission to Nigeria, led by Dr Seth Berkley, Chief Executive Officer of The Gavi Alliance and members of the Gavi Alliance at the State House, Abuja.

The President in a statement issued by Femi Adesina, his Special Adviser on Media and Publicity, said preliminary reports showed that coverage for the third dose of the pentavalent vaccine increased from 33 percent in 2017 to 63 percent in 2019.

He said the drop to 56 percent in 2021 was impacted by the COVID-19 pandemic, adding, “However, there is a lot more to do.’’

Buhari said the Federal Government would increase funding to the Health Sector through the Basic Healthcare Provision Fund and other initiatives.

“Gavi’s disbursement of a total sum of $1.5 billion in grants to support immunisation and health systems strengthening in Nigeria since 2001 has significant results, but I know that as partners we would all like to see this translated into an improvement in our health indices and outcomes, particularly in the area of maternal and newborn health.

“Our donors and partners have played their part in providing all the necessary support to improve our health outcomes. The responsibility therefore ultimately lies with the Federal and States Ministries of Health, the National Primary Healthcare Development Agency and other healthcare parastatals to place greater focus on exploring innovative ways of ending the lingering issues, improving accountability across board, and ensuring that value for money is prioritised in all health expenditure”, he said.

President Buhari noted Gavi Board’s exceptional approval for extension of Nigeria’s transition out of Gavi’s support, which was initially scheduled for 2022 to 2028, and the joint commitment of over $3 billion to fund vaccine procurement and health system strengthening interventions across the country.

“I assure you that the Government of Nigeria will sustain and improve our work on routine immunisation performance; contain outbreaks of the Circulating Vaccine-Derived Polio Virus, strengthen surveillance against Wild Polio Virus and curb the spread of the COVID-19 virus”, he said.

President Buhari assured that the Federal Government would continue to honour its funding commitment for traditional routine vaccines and co-financing the introduction of new vaccines into the country’s Expanded Programme on Immunisation schedule.

“We look forward to our continued cooperation with Gavi and other partners in our efforts to achieve the annual targets set out in Nigeria’s Strategy for Immunisation and Primary Health Care System Strengthening and towards the attainment of Universal Health Coverage”, President Buhari added.

In his remarks, the Minister of Health, Dr Osagie Ehanire, said the GAVI team was in Nigeria for the annual review of the implementation of the accountability framework of the Nigerian strategy on routine immunisation and also to support the establishment of a robust primary health care system in the country and access to vaccines.

He added that GAVI had also been of immense help in accessing the COVID-19 vaccines through the COVAX facility.

The Chief Executive Officer of The Gavi Alliance, said the last time he visited the country, the foundations of the 2018 Accountability Framework were still setting, and the follow up visit was an important opportunity to take stock of the progress being made.

“I am encouraged to be able to report that the Government’s commitment to primary health care and immunisation remains strong. While Covid-19 has set us all back, the ongoing response offers opportunities to strengthen systems to migrate against resurgence of the virus as well as the challenges of other vaccine preventable diseases”, he said.